Brief: India's Marksans Pharma March-Quarter Consol Profit Rises
02/06/2020 07:21
June 2 (Reuters) - Marksans Pharma Ltd MARK.NS :
* MARCH-QUARTER CONSOL PROFIT 427.4 MILLION RUPEES VERSUS
98.5
MILLION RUPEES YEAR AGO
* MARCH-QUARTER CONSOL REVENUE FROM OPERATIONS 3.35 BILLION
RUPEES
VERSUS 2.47 BILLION RUPEES YEAR AGO
Source text for Eikon: ID:nBSE2rnwDl
Further company coverage: MARK.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Marksans Pharma
See all newsIndia's Marksans Pharma jumps to over 18-month high after more than doubling quarterly profit
Brief: Marksans Pharma Ltd To Acquire 100% Of Netherlands-Based Qliniq B.V
India's Marksans Pharma jumps to 10-month high after Q4 profit rise
Brief: Marksans Pharma March-Quarter Consol Net Profit 1.48 Billion Rupees
Brief: Marksans Pharma Ltd Receives USFDA Approval For Benzonatate Capsules USP, 100 Mg & 200 Mg